Causes of Hypercalcemia: CHIMPANZEES

The CHIMPANZEES mnemonic covers all major causes: **C**alcium supplementation excess, **H**yperparathyroidism (primary — most common overall; tertiary in CKD), **I**mmobilization (increased bone resorption), **M**ilk-alkali syndrome, **P**aget disease (primarily with immobilization), **A**ddison's disease (adrenal insufficiency), **N**eoplasm/malignancy (second most common overall; most common inpatient cause — PTHrP, osteolytic mets, lymphoma via 1,25-OH-D), **Z**ollinger-Ellison (MEN1), **E**xcess vitamin D (granulomatous diseases: sarcoid, TB, histoplasma — macrophages convert 25-OH-D to active 1,25-OH-D), **E**ctopic PTH (rare), **S**arcoidosis and other granulomatous diseases. Primary hyperparathyroidism: high PTH + high calcium (50% asymptomatic, found on routine labs). Malignancy: suppressed PTH + very high calcium (PTHrP from squamous cell, renal, bladder cancers; osteolytic mets from breast, myeloma; lymphoma via calcitriol).

Clinical Features and Diagnosis

**Bones**: osteitis fibrosa cystica (primary HPT), pathologic fractures, subperiosteal bone resorption (radial aspect of middle phalanx on X-ray — classic HPT sign). **Stones**: nephrolithiasis (calcium oxalate/phosphate stones), nephrocalcinosis, nephrogenic DI, polyuria. **Groans**: nausea, vomiting, constipation, anorexia, peptic ulcers (gastrin stimulated by calcium), pancreatitis. **Psychic moans**: depression, cognitive dysfunction, lethargy, stupor, coma. **ECG**: shortened QT interval (calcium shortens phase 2 of cardiac action potential) — opposite of hypocalcemia. **Workup**: first check corrected calcium (add 0.8 mg/dL per 1 g/dL albumin below 4) or ionized calcium. Then PTH: if elevated → primary/tertiary HPT; if suppressed → malignancy workup (PTHrP, SPEP, imaging). Check PTHrP, vitamin D levels (25-OH and 1,25-OH), ACE level (sarcoid), SPEP.

Treatment by Severity

**Mild (10.5–12 mg/dL, asymptomatic)**: oral hydration, treat underlying cause. Monitor for worsening. **Moderate–severe (>12 or symptomatic)**: IV normal saline aggressive hydration (3–4 L in first few hours; furosemide only after adequate hydration to prevent pulmonary edema, NOT as first-line). **Bisphosphonates** (zoledronic acid or pamidronate): osteoclast inhibition — onset 24–48h, peak effect 2–4 days; drug of choice for malignancy-associated hypercalcemia. **Calcitonin**: fastest-acting (hours), but tachyphylaxis within 48h; useful as bridge until bisphosphonates kick in. **Corticosteroids**: for vitamin D-mediated hypercalcemia (sarcoid, lymphoma) — suppress macrophage 1α-hydroxylase. **Denosumab** (RANK-L inhibitor): useful when bisphosphonates fail. **Hemodialysis**: for severe hypercalcemia with renal failure. **Primary HPT management**: parathyroidectomy if symptomatic, Ca >1 mg/dL above normal, age <50, T-score ≤−2.5, 24h urine calcium >400 mg, or creatinine clearance <60.